Close

Janssen Research (JNJ) Reports Breakthrough Therapy Designation for Esketamine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. BA
5. SPOT
6. META
7. IBM
8. V
9. KMB
10. SPY


Go back to Janssen Research (JNJ) Reports Breakthrough Therapy Designation for Esketamine
Johnson & Johnson (NYSE: JNJ) Delayed: 148.53 -1.03 (0.69%)
Previous Close $149.56    52 Week High $126.07 
Open $148.14    52 Week Low $94.28 
Day High $148.99    P/E 30.88 
Day Low $146.86    EPS $4.81 
Volume 9,754,868